<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05795985</url>
  </required_header>
  <id_info>
    <org_study_id>4183</org_study_id>
    <nct_id>NCT05795985</nct_id>
  </id_info>
  <brief_title>Role of Faecal Calprotectin in Patients With Abdominal Pain</brief_title>
  <official_title>Role of Faecal Calprotectin in Patients Presenting to the Emergency Department With Abdominal Pain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fondazione Policlinico Universitario Agostino Gemelli IRCCS</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fondazione Policlinico Universitario Agostino Gemelli IRCCS</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The evaluation of patients with abdominal pain is a challenge for the emergency physician and&#xD;
      the selection of patients for second-level radiological examinations or endoscopic procedures&#xD;
      is not always easy to perform. Faecal calprotectin could be a useful diagnostic marker to&#xD;
      distinguish between &quot;organic&quot; or &quot;functional&quot; form and its determination could be helpful to&#xD;
      select patients for further examinations, in the context of emergency setting.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 1, 2021</start_date>
  <completion_date type="Actual">March 1, 2023</completion_date>
  <primary_completion_date type="Actual">December 31, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>inflammation</measure>
    <time_frame>3 days</time_frame>
    <description>assess the degree of intestinal inflammation by fecal calprotectin assay in patients with abdominal pain</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">146</enrollment>
  <condition>Inflammation</condition>
  <arm_group>
    <arm_group_label>abdominal pain</arm_group_label>
    <description>patients with abdominal pain</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>calprotectin levels</intervention_name>
    <description>dosage of calprotectin levels in patients with abdominal pain</description>
    <arm_group_label>abdominal pain</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patients with abdominal pain and/or diarrhea and/or rectal bleeding accessing the emergency&#xD;
        department&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patients with abdominal pain and/or diarrhea and/or rectal bleeding&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  patients with age &lt; 18 years&#xD;
&#xD;
          -  pregnant women;&#xD;
&#xD;
          -  patients with oncological, cardiological, nephrological terminal diseases;&#xD;
&#xD;
          -  patients on antibiotic therapy or who have taken it during the last month;&#xD;
&#xD;
          -  patients with a history of colic resection or gastrointestinal surgery;&#xD;
&#xD;
          -  patients with a previous diagnosis of inflammatory bowel disease (Crohn's disease,&#xD;
             ulcerative colitis)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>Fondazione Policlinico Universitario A. Gemelli IRCCS</name>
      <address>
        <city>Roma</city>
        <zip>00168</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>April 2023</verification_date>
  <study_first_submitted>March 21, 2023</study_first_submitted>
  <study_first_submitted_qc>March 21, 2023</study_first_submitted_qc>
  <study_first_posted type="Actual">April 3, 2023</study_first_posted>
  <last_update_submitted>April 1, 2023</last_update_submitted>
  <last_update_submitted_qc>April 1, 2023</last_update_submitted_qc>
  <last_update_posted type="Actual">April 4, 2023</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Fondazione Policlinico Universitario Agostino Gemelli IRCCS</investigator_affiliation>
    <investigator_full_name>OJETTI VERONICA</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Inflammation</mesh_term>
    <mesh_term>Abdominal Pain</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

